Your browser doesn't support javascript.
loading
Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN Trial.
Stockton, Shannon; Catalano, Paul; Cohen, Steven J; Burtness, Barbara A; Mitchell, Edith P; Dotan, Efrat; Lubner, Sam J; Kumar, Pankaj; Mulcahy, Mary F; Fisher, George A; Crandall, Theodore L; Benson, Al.
Affiliation
  • Stockton S; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Catalano P; Dana-Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston, MA, USA.
  • Cohen SJ; Jefferson Health System/Abington Memorial Hospital, Abington, PA, USA.
  • Burtness BA; Yale University, New Haven, CT, USA.
  • Mitchell EP; Thomas Jefferson University, Philadelphia, PA, USA.
  • Dotan E; Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Lubner SJ; University of Wisconsin, Madison, WI, USA.
  • Kumar P; Illinois CancerCare, Peoria, IL, USA.
  • Mulcahy MF; Northwestern University, Evanston, IL, USA.
  • Fisher GA; Stanford Cancer Center, Stanford University, Palo Alto, CA, USA.
  • Crandall TL; University of Pittsburgh, Pittsburgh, PA, USA.
  • Benson A; Northwestern University, Evanston, IL, USA.
Oncologist ; 28(9): 827-e822, 2023 09 07.
Article in En | MEDLINE | ID: mdl-37104870

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Esophageal Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2023 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Esophageal Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2023 Type: Article Affiliation country: United States